GeneDx (WGS) - 2023 Q4 - Earnings Call Presentation

Leading exome and genome products Translating complex genomic data into definitive diagnoses for patients Common diseases are in fact a constellation of genetic diagnoses 18Butler L. et al. Exome-based testing for patients with seizures: Advantages over panel-based testing. Poster presented at American Epilepsy SocietyAnnual Meeting; December 2, 2023; Orlando, FL. Data is at the center of our business Our huge dataset and intelligent interpretation platform set us apart and fuel innovation suboptimal care | ...